Perspectives of clients and providers on factors influencing opioid agonist treatment uptake among HIV-positive people w
- PDF / 1,150,154 Bytes
- 13 Pages / 595.276 x 790.866 pts Page_size
- 104 Downloads / 168 Views
Open Access
RESEARCH
Perspectives of clients and providers on factors influencing opioid agonist treatment uptake among HIV‑positive people who use drugs in Indonesia, Ukraine, and Vietnam: HPTN 074 study Tetiana Kiriazova1* , Vivian F. Go2, Rebecca B. Hershow2, Erica L. Hamilton3, Riza Sarasvita4, Quynh Bui5, Kathryn E. Lancaster6, Kostyantyn Dumchev1, Irving F. Hoffman7, William C. Miller6 and Carl A. Latkin8
Abstract Background: Opioid agonist treatment (OAT) is an effective method of addiction treatment and HIV prevention. However, globally, people who inject drugs (PWID) have insufficient OAT uptake. To expand OAT access and uptake, policymakers, program developers and healthcare providers should be aware of barriers to and facilitators of OAT uptake among PWID. Methods: As a part of the HPTN 074 study, which assessed the feasibility of an intervention to facilitate HIV treatment and OAT in PWID living with HIV in Indonesia, Ukraine, and Vietnam, we conducted in-depth interviews with 37 HIV-positive PWID and 25 healthcare providers to explore barriers to and facilitators of OAT uptake. All interviews were audio-recorded, transcribed, translated into English, and coded in NVivo for analysis. We developed matrices to identify emergent themes and patterns. Results: Despite some reported country-specific factors, PWID and healthcare providers at all geographic locations reported similar barriers to OAT initiation, such as complicated procedures to initiate OAT, problematic clinic access, lack of information on OAT, misconceptions about methadone, financial burden, and stigma toward PWID. However, while PWID reported fear of drug interaction (OAT and antiretroviral therapy), providers perceived that PWID prioritized drug use over caring for their health and hence were less motivated to take up ART and OAT. Motivation for a life change and social support were reported to be facilitators. Conclusion: These results highlight a need for support for PWID to initiate and retain in drug treatment. To expand OAT in all three countries, it is necessary to facilitate access and ensure low-threshold, financially affordable OAT programs for PWID, accompanied with supporting interventions. PWID attitudes and beliefs about OAT indicate the need for informational campaigns to counter misinformation and stigma associated with addiction and OAT (especially methadone).
*Correspondence: [email protected] 1 Ukrainian Institute On Public Health Policy, 5 Biloruska Str., Office 20, 27, Kyiv 04050, Ukraine Full list of author information is available at the end of the article © The Author(s) 2020. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s
Data Loading...
